Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
Christiane Rüster, Günter Wolf
Journal of the American Society of Nephrology (2006) Vol. 17, Iss. 11, pp. 2985-2991
Open Access | Times Cited: 455

Showing 1-25 of 455 citing articles:

Calcineurin Inhibitor Nephrotoxicity
Maarten Naesens, Dirk Kuypers, Minnie Sarwal
Clinical Journal of the American Society of Nephrology (2009) Vol. 4, Iss. 2, pp. 481-508
Open Access | Times Cited: 1363
Mechanisms of Tubulointerstitial Fibrosis
Michael Zeisberg, Eric G. Neilson
Journal of the American Society of Nephrology (2010) Vol. 21, Iss. 11, pp. 1819-1834
Closed Access | Times Cited: 822
Angiotensin II revisited: new roles in inflammation, immunology and aging
Ariela Benigni, Paola Cassis, Giuseppe Remuzzi
EMBO Molecular Medicine (2010) Vol. 2, Iss. 7, pp. 247-257
Open Access | Times Cited: 688
Obesity and Obesity-Initiated Metabolic Syndrome
Ihab Wahba, Robert H. Mak
Clinical Journal of the American Society of Nephrology (2007) Vol. 2, Iss. 3, pp. 550-562
Open Access | Times Cited: 491
Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system)
Hiep T. Nguyen, Carol B. Benson, Bryann Bromley, et al.
Journal of Pediatric Urology (2014) Vol. 10, Iss. 6, pp. 982-998
Open Access | Times Cited: 476
The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction
Robert L. Chevalier
AJP Renal Physiology (2016) Vol. 311, Iss. 1, pp. F145-F161
Open Access | Times Cited: 373
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus
Jun Cheng, Wen Zhang, Xiaohui Zhang, et al.
JAMA Internal Medicine (2014) Vol. 174, Iss. 5, pp. 773-773
Closed Access | Times Cited: 270
Uremic Toxins Induce Kidney Fibrosis by Activating Intrarenal Renin–Angiotensin–Aldosterone System Associated Epithelial-to-Mesenchymal Transition
Chiao-Yin Sun, Shih‐Chung Chang, Mai-Szu Wu
PLoS ONE (2012) Vol. 7, Iss. 3, pp. e34026-e34026
Open Access | Times Cited: 269
Cyclosporine: A Review
Dustin Tedesco, Lukas Haragsim
Journal of Transplantation (2012) Vol. 2012, pp. 1-7
Open Access | Times Cited: 266
Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
Helmy M. Siragy, Robert M. Carey
American Journal of Nephrology (2010) Vol. 31, Iss. 6, pp. 541-550
Open Access | Times Cited: 264
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage
Silvia Mennuni, Speranza Rubattu, Giorgia Pierelli, et al.
Journal of Human Hypertension (2013) Vol. 28, Iss. 2, pp. 74-79
Open Access | Times Cited: 252
Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome
Jacek Rysz, Anna Gluba-Brzózka, Beata Franczyk, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 8, pp. 1702-1702
Open Access | Times Cited: 243
Mechanisms of Metabolic Acidosis–Induced Kidney Injury in Chronic Kidney Disease
Donald E. Wesson, Jerry Buysse, David A. Bushinsky
Journal of the American Society of Nephrology (2020) Vol. 31, Iss. 3, pp. 469-482
Open Access | Times Cited: 142
From Acute to Chronic: Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease
Tzu-Hsuan Yeh, Kuan-Chieh Tu, Hsien‐Yi Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1755-1755
Open Access | Times Cited: 20
Angiotensin II–Induced Reactive Oxygen Species and the Kidney
Anja Sachse, Günter Wolf
Journal of the American Society of Nephrology (2007) Vol. 18, Iss. 9, pp. 2439-2446
Open Access | Times Cited: 278
Suppression of renin–angiotensin gene expression in the kidney by paricalcitol
Michael Freundlich, Yasmir Quiroz, Zhongyi Zhang, et al.
Kidney International (2008) Vol. 74, Iss. 11, pp. 1394-1402
Open Access | Times Cited: 263
Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease
Samuel N. Heyman, Mogher Khamaisi, Seymour Rosen, et al.
American Journal of Nephrology (2008) Vol. 28, Iss. 6, pp. 998-1006
Open Access | Times Cited: 194
Angiotensin II as a Morphogenic Cytokine Stimulating Renal Fibrogenesis
Christiane Rüster, Günter Wolf
Journal of the American Society of Nephrology (2011) Vol. 22, Iss. 7, pp. 1189-1199
Open Access | Times Cited: 185
Treatment of chronic kidney disease
Jeffrey M. Turner, Carolyn Bauer, Matthew K. Abramowitz, et al.
Kidney International (2011) Vol. 81, Iss. 4, pp. 351-362
Open Access | Times Cited: 167
Therapeutic targets for treating fibrotic kidney diseases
So‐Young Lee, Sung-Il Kim, Mary E. Choi
Translational research (2014) Vol. 165, Iss. 4, pp. 512-530
Open Access | Times Cited: 159
ACE Inhibition Is Renoprotective among Obese Patients with Proteinuria
Francesca Mallamaci, Piero Ruggenenti, Annalisa Perna, et al.
Journal of the American Society of Nephrology (2011) Vol. 22, Iss. 6, pp. 1122-1128
Open Access | Times Cited: 145
Renoprotective effects of vitamin D analogs
Yan Chun Li
Kidney International (2009) Vol. 78, Iss. 2, pp. 134-139
Open Access | Times Cited: 131
Nonclassical Renin‐Angiotensin System and Renal Function
Mark C. Chappell
Comprehensive physiology (2012), pp. 2733-2752
Open Access | Times Cited: 125
SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management
Lin Wu, Aislinn M. O'Kane, Peng Hu, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114114-114114
Open Access | Times Cited: 125
Targeting inflammation: New therapeutic approaches in chronic kidney disease (CKD)
Daniela Impellizzeri, Emanuela Esposito, James Attley, et al.
Pharmacological Research (2014) Vol. 81, pp. 91-102
Closed Access | Times Cited: 121
Page 1 - Next Page

Scroll to top